Eden Research (LON:EDEN) Shares Down 13.2% – Should You Sell?

Eden Research plc (LON:EDEN)’s share price fell 13.2% during mid-day trading on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares changed hands during mid-day trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The stock has a market capitalization of £14.35 million, a PE ratio of -9.42 and a beta of 0.92. The business’s 50 day moving average is GBX 3.36 and its 200 day moving average is GBX 3.71. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,296.97). Also, insider Alexander John Abrey purchased 167,947 shares of Eden Research stock in a transaction dated Tuesday, March 4th. The stock was acquired at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,542.54). Insiders acquired 1,391,473 shares of company stock worth $103,604,725 over the last 90 days. Company insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.